SGP8
Product Specifications
UNSPSC Description
SGP8 (IAVPGEVA) is an octapeptide produced by hydrolysis of soybean 11S globulin, which has the effects of regulating lipid metabolism, inflammation and fibrosis. SGP8 (IAVPGEVA) exhibits inhibitory activity against DPP4 and inhibits the JNK-c-Jun signaling pathway, and has the ability to inhibit non-alcoholic steatohepatitis (NASH)[1].
Target Antigen
Dipeptidyl Peptidase
Type
Peptides
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sgp8.html
Solubility
10 mM in DMSO
Smiles
N[C@]([C@@H](C)CC)([H])C(N[C@@H](C)C(N[C@@H](C(C)C)C(N1CCC[C@H]1C(NCC(N[C@H](C(N[C@@H](C(C)C)C(N[C@@H](C)C(O)=O)=O)=O)CCC(O)=O)=O)=O)=O)=O)=O
Molecular Weight
754.87
References & Citations
[1]Peng Ma,et al. IAVPGEVA: Orally Available DPP4-Targeting Soy Glycinin Derived Octapeptide with Therapeutic Potential in Nonalcoholic Steatohepatitis.Journal of Agricultural and Food Chemistry. 2024, 72, 13, 7167–7178.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P6177/SGP8-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P6177/
Clinical Information
No Development Reported
CAS Number
855790-98-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
